BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.48 USD | +1.47% |
|
+0.95% | -19.16% |
| Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
| Jun. 05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
ETFs positioned on Bristol-Myers Squibb Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 12.97% | 208 M€ | +13.89% | - | |
| 4.99% | 2 M€ | -.--% | ||
| 4.01% | 21 M€ | +8.41% | - | |
| 2.63% | 25 M€ | +16.34% | - | |
| 2.37% | 2 M€ | -25.75% | ||
| 2.29% | 30 M€ | +1.76% | - | |
| 2.08% | 9 M€ | -.--% | - | |
| 1.90% | 16 M€ | -3.37% | ||
| 1.85% | 2 M€ | +9.08% | ||
| 1.43% | 5 M€ | -72.95% | - | |
| 1.42% | 9 M€ | -4.31% | - | |
| 1.37% | 26 M€ | +16.85% | - | |
| 1.26% | 779 M€ | +4.17% | ||
| 1.00% | 86 M€ | +3.59% | ||
| 0.99% | 10 M€ | +10.28% | ||
| 0.83% | 108 M€ | +10.52% | ||
| 0.82% | 7 M€ | +5.53% | ||
| 0.80% | 2,334 M€ | +16.24% | ||
| 0.78% | 3 M€ | +15.16% | - | |
| 0.78% | 13 M€ | -.--% | - |
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
Pharmaceuticals
Calendar
2024-06-11
- Goldman Sachs Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.48
USD
Average target price
53.19
USD
Spread / Average Target
+28.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.16% | 84.08B | |
| +45.82% | 765B | |
| +40.95% | 632B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.45% | 248B | |
| -0.78% | 219B | |
| +11.88% | 216B | |
| +5.90% | 164B |
- Stock Market
- Equities
- BMY Stock
- Funds and ETFs Bristol-Myers Squibb Company
